# Evaluate the Efficacy of Adding Intraluminal Brachytherapy After CCRT for Local-regional Thoracic Esophageal Cancer.

> **NCT06365866** · NA · UNKNOWN · sponsor: **Taipei Veterans General Hospital, Taiwan** · enrollment: 20 (estimated)

## Conditions studied

- Esophageal Neoplasms
- Head and Neck Neoplasms
- Gastrointestinal Neoplasms
- Digestive System Diseases
- Digestive System Neoplasms
- Esophageal Diseases
- Neoplasms by Site
- Gastrointestinal Diseases
- Neoplasms

## Interventions

- **DEVICE:** "BRAXX" Esophageal Brachytherapy Applicator.
- **RADIATION:** Add-on of intraluminal brachytherapy

## Key facts

- **NCT ID:** NCT06365866
- **Lead sponsor:** Taipei Veterans General Hospital, Taiwan
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-02-19
- **Primary completion:** 2024-12
- **Final completion:** 2024-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2024-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06365866

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06365866, "Evaluate the Efficacy of Adding Intraluminal Brachytherapy After CCRT for Local-regional Thoracic Esophageal Cancer.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06365866. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*